Biotech

All Articles

F 2G raises $100M for 2nd try to get brand new antifungal to market

.After F2G's 1st try to acquire a brand-new course of antifungal to market was thwarted by the FDA, ...

Moderna targets $1.1 B in R&ampD costs slices, drops 5 systems among productivity tensions

.Moderna has actually promised to reduce R&ampD investing by $1.1 billion through 2027. The decision...

Sanofi's $80M bet on Pivot dystrophy drug finishes in phase 3 go bust

.Just four months after Sanofi wager $80 million in ahead of time cash money on Fulcrum Therapies' l...

Oncternal share sinks 60% in the middle of discharges, test discontinuations

.Cancer company Oncternal Therapeutics is actually folding all its own clinical tests and also givin...

Roche is actually holding out chances that its own injectable weight problems prospect could at some point show 25% effective weight loss in late-stage test

.Roche is storing out chances that its own injectable obesity possibility might at some point displa...

Novo Nordisk hails 'impressive' weight reduction result for dual-acting oral drug in early test

.Novo Nordisk has actually lifted the lid on a period 1 test of its own dental amylin and GLP-1 rece...

AbbVie takes legal action against BeiGene over blood cancer medication classified information

.Merely a handful of quick weeks after gaining an FDA Fast lane tag for its own investigational BTK ...

Lilly supplies one-two blow along with second tranche of positive information on weekly the hormone insulin prospect

.Quickly after a beneficial records decrease for Eli Lilly's efsitora alfa, the Indianapolis-based f...

BridgeBio reduces genetics therapy finances as medical information dissatisfy

.BridgeBio Pharma is lowering its own genetics treatment budget and also pulling back from the metho...

GSK surrenders HSV vaccine wishes after phase 2 fail, delivering nationality to Moderna, BioNTech

.GSK's effort to create the very first vaccine for genital herpes simplex virus (HSV) has ended in f...